Strategic Initiative
Slingshot members are tracking this corporate initiative:
Lannett Company plans to co-develop generic insulin for the U.S. market with its strategic partner in China, YiChang HEC ChangJiang Pharmaceutical, an HEC Group company. The product is currently in late stage development
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Apr 22, 2016 Projected Implementation: Q2, 2016 Relevance Tracked Until: Q1, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Generic Insulin, Oseltamivir Phosphate, Anti-viral Products, Generic Pharmaceutical Products